Application of methods for central statistical monitoring in clinical trials

Kirkwood, Amy A; Cox, Trevor; Hackshaw, Allan
October 2013
Clinical Trials;Oct2013, Vol. 10 Issue 5, p783
Academic Journal
No abstract available.


Related Articles

  • Alternatives to parallel group design suggested for trials.  // British Journal of Hospital Medicine (17508460);2015, Vol. 76 Issue 7, p383 

    The article reports on the research on alternatives to parallel group design suggested for trials to make it cheaper and easier to run, referencing a study by R. Hooper and L. Bourke published in a 2015 issue of "British Medical Journal."

  • Data monitoring committees for pragmatic clinical trials. Ellenberg, Susan S.; Culbertson, Richard; Gillen, Daniel L.; Goodman, Steven; Schrandt, Suzanne; Zirkle, Maryan // Clinical Trials;Oct2015, Vol. 12 Issue 5, p530 

    In any clinical trial, it is essential to monitor the accumulating data to be sure that the trial continues to be safe for participants and that the trial is being conducted properly. Data monitoring committees, independent expert panels who undertake regular reviews of the data as the trial...

  • Influence of trial design, heterogeneity and regulatory environment on the results of clinical trials: An appraisal in the context of recent trials on acute stroke intervention. Srijithesh, P. R.; Husain, Shakir // Annals of Indian Academy of Neurology;Oct2014, Vol. 17 Issue 4, p365 

    The outcome of randomized controlled trials can vary depending on the eligibility criteria of the patients entering into the trial, as well as the heterogeneity of the eligible population and/or the interventions. If the subject population and/or interventions are heterogeneous, the final...

  • Eligibility for clinical trials in primary Sjögren's syndrome: lessons from the UK Primary Sjögren's Syndrome Registry. Oni, Clare; Mitchell, Sheryl; James, Katherine; Wan-Fai Ng; Griffiths, Bridget; Hindmarsh, Victoria; Price, Elizabeth; Pease, Colin T.; Emery, Paul; Lanyon, Peter; Jones, Adrian; Bombardieri, Michele; Sutcliffe, Nurhan; Pitzalis, Costantino; Hunter, John; Gupta, Monica; McLaren, John; Cooper, Annie; Regan, Marian; Giles, Ian // Rheumatology;Mar2016, Vol. 55 Issue 3, p544 

    Objective: To identify numbers of participants in the UK Primary Sjögren's Syndrome Registry (UKPSSR) who would fulfil eligibility criteria for previous/current or potential clinical trials in primary SS (pSS) in order to optimize recruitment. Methods: We did a retrospective analysis of...

  • New Developments in Medical Clinical Trials. D'Agostino Sr., R. B.; Massaro, J. M. // Journal of Dental Research;Jul2004 Supplement 1, pC18 

    This paper reviews several new developments and longstanding good practices for conducting clinical trials. Discussion starts with the need for clear statements of study objectives, proceeds to clarify target and sample population, and elaborates on primary vs. secondary variables with the need...

  • After Inclusion, Information and Inference: Reporting on Clinical Trials Results After 15 Years of Monitoring Inclusion of Women. Foulkes, Mary A. // Journal of Women's Health (15409996);Jun2011, Vol. 20 Issue 6, p829 

    Objective: The objectives of this report are to review the publications resulting from National Institutes of Health (NIH)-funded phase 3 trials monitored by NIH for inclusion and to address the quality of the research conducted and the validity of the sex/gender-specific or sex/gender...

  • Response from the author. Vickers, Andrew J // Clinical Trials;Dec2014, Vol. 11 Issue 6, p628 

    No abstract available.

  • Clinician-trialist rounds: 18. Should young (and old!) clinician-trialists perform single-arm Phase II futility trials? Sackett, David L // Clinical Trials;Dec2013, Vol. 10 Issue 6, p987 

    No abstract available.

  • Effort Required in Eligibility Screening for Clinical Trials. Penberthy, Lynne T.; Dahman, Bassam A.; Petkov, Valentina I.; Deshazo, Jonathan P. // Journal of Oncology Practice;Nov2012, Vol. 8 Issue 6, p365 

    Purpose: Determining eligibility for a clinical trial (CT) typically requires a lengthy manual review of data for a single evaluation. The cost associated with eligibility screening is typically not compensated through contracts supporting CTs. Methods: We used a real-time tracking system that...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics